Keap1-p-p62-IN-1
Keap1-p-p62-IN-1 is a potent and selective Keap1-p-p62 inhibitor with an IC50 of 0.11 μM. Keap1-p-p62-IN-1 shows 18.73-fold selectivity over Keap1-Nrf2 interaction. Keap1-p-p62-IN-1 normalizes Nrf2 ubiquitination, sensitizes cells to Sorafenib (HY-10201)-induced ferroptosis. Keap1-p-p62-IN-1 can be used for the research of p62 aberrant hepatocellular carcinoma.
For research use only. We do not sell to patients.
- Formula: C33H35N5O5S
- Molecular Weight:613.73
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
In Vitro
Keap1-p-p62-IN-1 (compound 13) (0.625-5 μM; 48 h) induces ferroptosis in p62-aberrant Huh-1 HCC cells in a Keap1-dependent manner, as evidenced by concentration-dependent downregulation of ferroptosis-related proteins/genes, GSH depletion, iron overload, and increased lipid peroxidation (MDA, 4-HNE, Liperfluo)[1].
Keap1-p-p62-IN-1 (0.03-5 μM; 24-72 h) selectively disrupts Keap1-p-p62 PPI in a dose- and time-dependent manner, causing increased Nrf2 ubiquitination in HEK293T and Huh-1 cells[1].
Keap1-p-p62-IN-1 (0.625-5 μM; 24-72 h) specifically inhibits Nrf2 activity in tumor
cells (Huh-1; Huh-7; AML 12; A549) with p62-dependent overactivation of Nrf2[1].
Keap1-p-p62-IN-1 (1.25-10 μM; 48 h) induces ferroptosis in specific HCC cells[1].
Keap1-p-p62-IN-1 (1.25-10 μM; 14 days) dose-dependently inhibits colony formation in Huh-1 HCC cells[1].
Keap1-p-p62-IN-1 (1.25-10 μM; 24-72 h) selectively induces ferroptosis in Huh-1 HCC cells with p62-dependent overactivation of Nrf2[1].
Keap1-p-p62-IN-1 (2.5-10 μM; 24 h-14 days)sensitizes Huh-1 cells bearing p62-mediated Nrf2 hyper-activation to Sorafenib by cooperatively inducing ferroptosis[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:HEK293T, Huh-1 cells
-
Concentration:0.03; 0.1; 0.3 μM (HEK293T), 2.5; 5 μM (Huh-1 cells)
-
Incubation Time:24; 36; 48; 72 h
-
Result:Effectively interfered with the Keap1−p-p62 interaction in a concentration-dependent manner without affecting the Keap1-Nrf2 interaction.
Barely disrupted the binding of both ETGE and DLGex motifs to Keap1.
Recovered the ability of Keap1 to interact with Nrf2 because of the elevated level of p62-free Keap1, leading to a decrease in the Nrf2 protein level of total cell lysate.
Elevated the accumulation of ubiquitinated Nrf2 upon MG132 (HY-13259) treatment.
Caused a time-dependent reduction in Nrf2 protein in both the nucleus and cytoplasm.
Showed a remarkable upregulation of the protein level of Keap1.
-
Cell Line:Huh-1 cells
-
Concentration:2.5; 5 μM
-
Incubation Time:24; 36; 48; 72 h
-
Result:Had no significant effect on the transcription level of NFE2L2 (encoding Nrf2 protein) in Huh-1 cells.
Concentration-dependently reduced mRNA levels of SLC7A11, FTL, and GPX4.
-
Cell Line:Huh-1; Huh-7; AML 12; A549
-
Concentration:0.625; 1.25; 2.5; 5 μM
-
Incubation Time:24; 36; 48; 72 h
-
Result:Decreased the protein levels of Nrf2 and its downstream genes in a concentration- and time-dependent manner, including gluta-
mate-cysteine ligase catalytic subunit (GCLC), NAD(P)H dehydrogenase (quinone) 1 (NQO1), and heme oxygenase-1 (HO-1).
Downregulate the protein levels of these ferroptosis-related genes in a concentration-dependent manner.
-
Cell Line:Huh-1; Huh-7; AML 12; A549
-
Concentration:0.625; 1.25; 2.5; 5 μM
-
Incubation Time:24; 36; 48; 72 h
-
Result:Significantly downregulated the
mRNA levels of Nrf2-regulated genes GCLC, NQO1, and HO-1, with IC50 values of 4.62 μM, 4.24 μM, and 3.51 μM, respectively.
Induced a time-dependent decrease in the mRNA expression of GCLC, NQO1, and HO-1.
-
Cell Line:Huh-1 HCC cells
-
Concentration:1.25; 2.5; 5; 10 μM
-
Incubation Time:48 h
-
Result:Decreased cell viability in a dose-dependent manner.
The growth inhibition induced by 13 in Huh-1 cells was mitigated by Fer-1 (5 μM).
-
Cell Line:Huh-1 HCC cells
-
Concentration:1.25; 2.5; 5; 10 μM
-
Incubation Time:14 days
-
Result:Inhibited colony formation of Huh-1 HCC cells in a dose-dependent manner.
Parmacokinetics
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:BALB/c nude mice (female) subcutaneously inoculated with Huh-1 cells[1]
-
Dosage:20; 40 mg/kg
-
Administration:i.p.; daily; 28 days
-
Result:Achieved a tumor growth inhibition (TGI) rate of 11.1% at 20 mg/kg.
Achieved a TGI of 30.1% at 40 mg/kg.
Decreased protein levels of Nrf2, glutamate-cysteine ligase catalytic subunit (GCLC), solute carrier family 7 member 11 (SLC7A11), and glutathione peroxidase 4 (GPX4) in tumor tissues.
Reduced glutathione (GSH) levels in tumor tissues.
Increased ferrous iron (Fe2+) levels in tumor tissues.
Increased malondialdehyde (MDA) levels in tumor tissues.
Caused no significant body weight loss or histopathological lesions in major organs.
Chemical Information
-
Molecular Weight 613.73
-
Formula C33H35N5O5S
-
SMILES
CC1=CC(C)=C(S(N(C2=C(C=CC=C3)C3=C(OC(C4=CC=C(C(C)(C)C)C=C4)C(O)=O)C=C2)CC5=NN=NN5)(=O)=O)C(C)=C1
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Autophagy
Autophagy is a process in which eukaryotic cells use lysosomes to degrade their own cytoplasmic proteins and damaged organelles under the regulation of autophagy related gene (Atg). Microtubule-associated proteins light chain 3 (LC3) is recognized as autophagy marker, which transfers from cytoplasmic LC3 (LC3-I) to membrane type (LC3-II). LC3-II/I ratio could be detected by Western Blot and fluorescence microscopy.
-
Ferroptosis Solutions
Ferroptosis is an iron-dependent, non-apoptotic form of regulated cell death characterized by lethal lipid peroxidation and sensitivity to suppression by iron chelators or lipophilic radical-trapping antioxidants. The core pathway links cystine uptake through system Xc−, glutathione availability, GPX4-dependent detoxification of phospholipid hydroperoxides, iron-dependent oxidative reactions, and polyunsaturated-phospholipid metabolism into a cell-death program that is biochemically and morphologically distinct from apoptosis, necrosis, and autophagy. The ferroptosis pathway is experimentally linked to phenotype through chemical and genetic perturbation. Erastin induces ferroptosis by inhibiting cystine uptake through system Xc− and weakening antioxidant defenses, while GPX4 inhibition or depletion causes lipid peroxide accumulation and ferroptotic cancer-cell death. ACSL4 and oxidizable arachidonoyl- or adrenoyl-containing phosphatidylethanolamines shape ferroptosis sensitivity by con
-
Liver Cancer Modeling
Liver cancer can be classified into primary liver cancer and secondary liver cancer. Secondary liver cancer is the metastatic liver cancer. Primary liver cancer includes hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (ICC) and fibrolamellar HCC, of which HCC is the most common form, accounting for approximately 90% of primary liver cancers[1]. HCC mouse models include chemical agent-induced models, transplanted tumor models, and genetic engineered models.
-
Macroautophagy Solutions
Macroautophagy is a conserved lysosome-dependent degradation pathway in which cytoplasmic material is sequestered into double-membrane autophagosomes and delivered to lysosomes for degradation and recycling. The pathway supports cellular homeostasis during nutrient limitation, organelle stress, protein-aggregate accumulation, infection, differentiation, and tissue remodeling by coupling cargo sequestration, autophagosome maturation, lysosomal fusion, and degradation of cargo-derived macromolecules. The core molecular sequence includes initiation by nutrient- and stress-regulated autophagy machinery, autophagosome nucleation, LC3/ATG8-family conjugation to autophagosomal membranes, cargo selection through receptors such as SQSTM1/p62, autophagosome-lysosome fusion, and lysosomal degradation. LC3 was identified as a mammalian homolog of yeast Atg8 that localizes to autophagosomal membranes after processing, and p62/SQSTM1 was shown to connect ubiquitinated cargo with autophagic degradati
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)